Diffuse cutaneous systemic sclerosis

Disease ID:285
Name:Diffuse cutaneous systemic sclerosis
Associated with:1 targets
0 immuno-relevant targets
1 immuno-relevant ligands
Database Links
Orphanet: ORPHA220393

Targets

Ligands

Ligand Approved Immuno References Clinical comments
IL-13
Immuno Disease Comments: Drug target for diffuse systemic sclerosis- see Phase 2 trial NCT02921971 which is evaluating the anti-IL-4/IL-13 bispecific monoclonal antibody SAR156597.